In what amounts to the latest powerhouse European partnership born of a joint mHealth effort, AstraZeneca and Exco InTouch have announced a groundbreaking program to “develop and launch interactive mobile phone and internet-based health tools.”
The goal of the partnership is to help patients in the United Kingdom and their health care providers track and manage chronic conditions.
AstraZeneca’s R&D organization and Exco InTouch are developing the tool with an initial focus on chronic obstructive pulmonary disease (COPD).
In a press release issued Thursday, the companies explained that patients enrolled in the programs will have the opportunity to access personalized coaching and information about their disease and treatment via their mobile phones or other web enabled devices.
We’re told that patients will also use digital technology to collect, transmit and review their own clinical data.
“Patients and their health care providers will be able to use this real-time information to make informed decisions and tailor care pathways to personalize each patient’s disease management and optimize health outcomes,” the announcement reads.
To learn more about the partnership and its mHealth aims, click here.